Evidence map›Paper›PMID 40470539›Full record

ArticleThe Journal of infectious diseases2025

Immunotherapy for Infectious Diseases: Back to the Future.

Jatin M Vyas

Abstract readEditorialComment
In one paragraph

Article in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Jatin M VyasVagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.ORCID 0000-0002-9985-9565

Funding

Control of Type I Interferon Production in Response to Candida albicansR01AI150181 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Jatin M Vyas · 2020 to 2026
$5.4M
Pathways to Mentorship and Research: Training the Next Generation Physician-ScientistsR25AI147393 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI VYAS, JATIN M · 2019 to 2024
$1.8M
MGH Next Generation Physician-Scientist Through Stimulating Access to Research in Residency Program (MGH-Next Gen StARR)R38HL150212 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI VYAS, JATIN M · 2020 to 2023
$1.3M
NIH HHS R01AI150181NIH HHS R25AI147393NIH HHS R38AG070229)NIH HHS R38HL150212
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibioticscellular therapyhistory of infectious diseasesimmunoengineeringimmunotherapy

Identifiers

PMID40470539
PMCPMC12308665

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.